These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9344472)

  • 21. Wheat-germ aspartate transcarbamoylase. Steady-state kinetics and stereochemistry of the binding site for L-aspartate.
    Grayson JE; Yon RJ; Butterworth PJ
    Biochem J; 1979 Nov; 183(2):247-54. PubMed ID: 534495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weakening of the interface between adjacent catalytic chains promotes domain closure in Escherichia coli aspartate transcarbamoylase.
    Baker DP; Fetler L; Keiser RT; Vachette P; Kantrowitz ER
    Protein Sci; 1995 Feb; 4(2):258-67. PubMed ID: 7757014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of an active site histidine in the catalytic mechanism of aspartate transcarbamoylase.
    Kleanthous C; Wemmer DE; Schachman HK
    J Biol Chem; 1988 Sep; 263(26):13062-7. PubMed ID: 3047117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural consequences of the replacement of Glu239 by Gln in the catalytic chain of Escherichia coli aspartate transcarbamylase.
    Tauc P; Vachette P; Middleton SA; Kantrowitz ER
    J Mol Biol; 1990 Jul; 214(1):327-35. PubMed ID: 1973463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Function of serine-171 in domain closure, cooperativity, and catalysis in Escherichia coli aspartate transcarbamoylase.
    Dembowski NJ; Newton CJ; Kantrowitz ER
    Biochemistry; 1990 Apr; 29(15):3716-23. PubMed ID: 2111165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A facile enzymatic technique for the estimation of nanomolar concentrations of N-phosphonacetyl-L-aspartic acid in plasma.
    Kensler TW; Jayaram HN; Cooney DA
    J Biochem Biophys Methods; 1980; 2(1):29-35. PubMed ID: 6999068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ionization of amino acid residues involved in the catalytic mechanism of aspartate transcarbamoylase.
    Turnbull JL; Waldrop GL; Schachman HK
    Biochemistry; 1992 Jul; 31(28):6562-9. PubMed ID: 1633167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase.
    Eldo J; Heng S; Kantrowitz ER
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2086-90. PubMed ID: 17336518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspartate transcarbamoylase from Phaseolus aureus. Partial purification and properties.
    Ong BL; Jackson JF
    Biochem J; 1972 Sep; 129(3):571-81. PubMed ID: 4658988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of new transition-state analogue inhibitors of aspartate transcarbamylase.
    Farrington GK; Kumar A; Wedler FC
    J Med Chem; 1985 Nov; 28(11):1668-73. PubMed ID: 4067992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The catalytic site of Escherichia coli aspartate transcarbamylase: interaction between histidine 134 and the carbonyl group of the substrate carbamyl phosphate.
    Xi XG; Van Vliet F; Ladjimi MM; Cunin R; Hervé G
    Biochemistry; 1990 Sep; 29(36):8491-8. PubMed ID: 2252907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspartate transcarbamylase from the hyperthermophilic archaeon Pyrococcus abyssi. Insights into cooperative and allosteric mechanisms.
    Van Boxstael S; Maes D; Cunin R
    FEBS J; 2005 Jun; 272(11):2670-83. PubMed ID: 15943802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ behavior of the pyrimidine pathway enzymes in Saccharomyces cerevisiae. 2. Reaction mechanism of aspartate transcarbamylase dissociated from carbamylphosphate synthetase by genetic alteration.
    Belkaïd M; Penverne B; Denis M; Hervé G
    Arch Biochem Biophys; 1987 May; 254(2):568-78. PubMed ID: 3555346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic mechanism of catalytic subunits (c3) of E. coli aspartate transcarbamylase at pH 7.0.
    Hsuanyu Y; Wedler FC
    Biochim Biophys Acta; 1988 Dec; 957(3):455-8. PubMed ID: 3058211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient synthesis of fluorothiosparfosic acid analogues with potential antitumoral activity.
    Pfund E; Lequeux T; Masson S; Vazeux M; Cordi A; Pierre A; Serre V; Hervé G
    Bioorg Med Chem; 2005 Aug; 13(16):4921-8. PubMed ID: 15975800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic parameters of aspartate transcarbamylase in human normal and tumoral cell lines.
    Baillon J; Guichard M; Malaise EP; Hervé G
    Cancer Res; 1983 May; 43(5):2277-82. PubMed ID: 6831451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of the quaternary structure change of aspartate transcarbamylase triggered by succinate, a competitive inhibitor.
    Tsuruta H; Vachette P; Sano T; Moody MF; Amemiya Y; Wakabayashi K; Kihara H
    Biochemistry; 1994 Aug; 33(33):10007-12. PubMed ID: 8060968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
    Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
    Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Steinberg SM; Hamilton JM; Murphy RF; Drake J; Chisena T; Balis F; Cysyk R; Arbuck SG
    Cancer Res; 1993 Oct; 53(20):4828-36. PubMed ID: 8402669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorus-containing inhibitors of aspartate transcarbamoylase from Escherichia coli.
    Laing NM; Chan WW; Hutchinson DW; Oberg B
    FEBS Lett; 1990 Jan; 260(2):206-8. PubMed ID: 2153584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.